Cargando…
NOXA as critical mediator for drug combinations in polychemotherapy
During polychemotherapy, cytotoxic drugs are given in combinations to enhance their anti-tumor effectiveness. For most drug combinations, underlying signaling mechanisms responsible for positive drug–drug interactions remain elusive. Here, we prove a decisive role for the Bcl-2 family member NOXA to...
Autores principales: | Ehrhardt, H, Höfig, I, Wachter, F, Obexer, P, Fulda, S, Terziyska, N, Jeremias, I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388227/ https://www.ncbi.nlm.nih.gov/pubmed/22717582 http://dx.doi.org/10.1038/cddis.2012.53 |
Ejemplares similares
-
Acute pancreatitis associated with multibacillary polychemotherapy
for leprosy
por: Maciel, Lucas Guimarães, et al.
Publicado: (2021) -
Efficient RNA interference in patients' acute lymphoblastic leukemia cells amplified as xenografts in mice
por: Höfig, Ines, et al.
Publicado: (2012) -
Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis
por: Ehrhardt, H, et al.
Publicado: (2013) -
Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications
por: Boggio, Elena, et al.
Publicado: (2023) -
The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of Lymphosarcoma
por: Sen'kova, Alexandra V., et al.
Publicado: (2012)